0000095953December 312022Q1falseP8Yhttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortizationhttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization00000959532022-01-012022-03-3100000959532022-05-09xbrli:shares00000959532022-03-31iso4217:USD00000959532021-12-31iso4217:USDxbrli:shares00000959532021-01-012021-03-3100000959532020-12-3100000959532021-03-310000095953us-gaap:CommonStockMember2021-12-310000095953us-gaap:AdditionalPaidInCapitalMember2021-12-310000095953us-gaap:RetainedEarningsMember2021-12-310000095953us-gaap:TreasuryStockMember2021-12-310000095953us-gaap:RetainedEarningsMember2022-01-012022-03-310000095953us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000095953us-gaap:TreasuryStockMember2022-01-012022-03-310000095953us-gaap:CommonStockMember2022-03-310000095953us-gaap:AdditionalPaidInCapitalMember2022-03-310000095953us-gaap:RetainedEarningsMember2022-03-310000095953us-gaap:TreasuryStockMember2022-03-310000095953us-gaap:CommonStockMember2020-12-310000095953us-gaap:AdditionalPaidInCapitalMember2020-12-310000095953us-gaap:RetainedEarningsMember2020-12-310000095953us-gaap:TreasuryStockMember2020-12-310000095953us-gaap:RetainedEarningsMember2021-01-012021-03-310000095953us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000095953us-gaap:TreasuryStockMember2021-01-012021-03-310000095953us-gaap:CommonStockMember2021-03-310000095953us-gaap:AdditionalPaidInCapitalMember2021-03-310000095953us-gaap:RetainedEarningsMember2021-03-310000095953us-gaap:TreasuryStockMember2021-03-310000095953synl:DanChemTechnologiesIncMember2021-10-222021-10-220000095953us-gaap:BaseRateMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:ABLLineOfCreditDueJanuary152025Member2021-10-222021-10-22xbrli:pure0000095953us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:ABLLineOfCreditDueJanuary152025Member2021-10-222021-10-220000095953synl:DanChemTechnologiesIncMember2021-10-220000095953synl:DanChemTechnologiesIncMember2022-01-012022-03-310000095953synl:DanChemTechnologiesIncMemberus-gaap:CustomerRelationshipsMember2021-10-220000095953synl:DanChemTechnologiesIncMembersynl:ProductDevelopmentKnowHowMember2021-10-220000095953synl:DanChemTechnologiesIncMemberus-gaap:TradeNamesMember2021-10-220000095953synl:FiberglassAndSteelLiquidStorageTanksAndSeparationEquipmentMember2022-01-012022-03-310000095953synl:FiberglassAndSteelLiquidStorageTanksAndSeparationEquipmentMember2021-01-012021-03-310000095953synl:SeamlessCarbonSteelPipeAndTubeMember2022-01-012022-03-310000095953synl:SeamlessCarbonSteelPipeAndTubeMember2021-01-012021-03-310000095953synl:StainlessSteelPipeMember2022-01-012022-03-310000095953synl:StainlessSteelPipeMember2021-01-012021-03-310000095953synl:GalvanizedPipeMember2022-01-012022-03-310000095953synl:GalvanizedPipeMember2021-01-012021-03-310000095953synl:SpecialtyChemicalsMember2022-01-012022-03-310000095953synl:SpecialtyChemicalsMember2021-01-012021-03-310000095953us-gaap:FairValueInputsLevel3Membersynl:MarcegaliaUSAInc.GalvanizedMember2021-12-310000095953synl:AmericanStainlessTubingInc.Memberus-gaap:FairValueInputsLevel3Member2021-12-310000095953us-gaap:FairValueInputsLevel3Member2021-12-310000095953us-gaap:FairValueInputsLevel3Membersynl:MarcegaliaUSAInc.GalvanizedMember2022-01-012022-03-310000095953synl:AmericanStainlessTubingInc.Memberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310000095953us-gaap:FairValueInputsLevel3Member2022-01-012022-03-310000095953us-gaap:FairValueInputsLevel3Membersynl:MarcegaliaUSAInc.GalvanizedMember2022-03-310000095953synl:AmericanStainlessTubingInc.Memberus-gaap:FairValueInputsLevel3Member2022-03-310000095953us-gaap:FairValueInputsLevel3Member2022-03-310000095953srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2022-03-310000095953synl:MeasurementInputFutureRevenueProjectionMembersrt:MaximumMember2022-01-012022-03-310000095953synl:MeasurementInputFutureRevenueProjectionMembersrt:WeightedAverageMember2022-01-012022-03-310000095953us-gaap:DiscontinuedOperationsHeldforsaleMembersynl:PalmerFacilityMember2022-03-310000095953us-gaap:DiscontinuedOperationsHeldforsaleMembersynl:PalmerFacilityMember2021-12-310000095953us-gaap:LandMember2022-03-310000095953us-gaap:LandMember2021-12-310000095953us-gaap:LandImprovementsMember2022-03-310000095953us-gaap:LandImprovementsMember2021-12-310000095953us-gaap:BuildingMember2022-03-310000095953us-gaap:BuildingMember2021-12-310000095953us-gaap:MachineryAndEquipmentMember2022-03-310000095953us-gaap:MachineryAndEquipmentMember2021-12-310000095953us-gaap:ConstructionInProgressMember2022-03-310000095953us-gaap:ConstructionInProgressMember2021-12-310000095953us-gaap:CostOfSalesMember2022-03-310000095953us-gaap:CostOfSalesMember2021-03-310000095953us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-03-310000095953us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-03-310000095953srt:MinimumMember2022-01-012022-03-310000095953srt:MaximumMember2022-01-012022-03-310000095953us-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2022-03-310000095953us-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-12-310000095953synl:TermLoanDueJanuary152025Memberus-gaap:SecuredDebtMember2022-03-310000095953synl:TermLoanDueJanuary152025Memberus-gaap:SecuredDebtMember2021-12-310000095953us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-152021-01-150000095953us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-150000095953us-gaap:LineOfCreditMembersynl:TheFacilityMember2021-01-150000095953synl:DelayedDrawTermLoanMembersynl:TheFacilityMember2021-01-150000095953synl:MachineryAndEquipmentSubLimitMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-150000095953synl:MachineryAndEquipmentSubLimitMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-152021-01-150000095953us-gaap:SecuredDebtMembersynl:TheFacilityMember2021-01-152021-01-150000095953us-gaap:BaseRateMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-152021-01-150000095953us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2021-01-152021-01-150000095953synl:DelayedDrawTermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMembersynl:TheFacilityMember2021-01-152021-01-150000095953us-gaap:LineOfCreditMembersynl:TheFacilityMember2022-03-310000095953us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembersynl:TheFacilityMember2022-03-310000095953synl:FirstShareRepurchaseProgramMember2021-02-172021-02-1700000959532021-02-170000095953synl:AmendedShareRepurchaseProgramMember2021-02-172021-02-17synl:segment0000095953synl:MetalsSegmentMember2022-01-012022-03-31synl:reporting_unit0000095953synl:SpecialtyChemicalsSegmentMember2022-01-012022-03-310000095953synl:MetalsSegmentMember2021-01-012021-03-310000095953synl:SpecialtyChemicalsSegmentMember2021-01-012021-03-310000095953synl:MetalsSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000095953synl:MetalsSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000095953synl:SpecialtyChemicalsSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000095953synl:SpecialtyChemicalsSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000095953us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000095953us-gaap:CorporateNonSegmentMember2021-01-012021-03-310000095953synl:MetalsSegmentMemberus-gaap:OperatingSegmentsMember2022-03-310000095953synl:MetalsSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310000095953synl:SpecialtyChemicalsSegmentMemberus-gaap:OperatingSegmentsMember2022-03-310000095953synl:SpecialtyChemicalsSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310000095953us-gaap:CorporateNonSegmentMember2022-03-310000095953us-gaap:CorporateNonSegmentMember2021-12-31


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended March 31, 2022
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from _____ to _____

COMMISSION FILE NUMBER 0-19687
synl-20220331_g1.jpg
Synalloy Corporation
(Exact name of registrant as specified in its charter)
Delaware57-0426694
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
1400 16th Street,Suite 270,
Oak Brook,Illinois60523
(Address of principal executive offices)(Zip Code)
(804)822-3260
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of exchange on which registered
Common Stock, par value $1.00 per shareSYNLNASDAQ Global Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes x  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerNon-accelerated filer
x
Smaller reporting company
x
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes   No
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes     No x
The number of shares outstanding of the registrant's common stock as of May 9, 2022 was 10,239,998
1



Synalloy Corporation
Table of Contents
 
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
 
 
 
Item 2.
Item 3.
Item 4.
PART II. OTHER INFORMATION
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
2


Forward-Looking Statements
This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government’s response to COVID-19; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs; raw material availability; financial stability of the Company’s customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company’s debt financing arrangements; and other risks detailed from time-to-time in Synalloy Corporation's Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC. Synalloy Corporation assumes no obligation to update any forward-looking information included in this release.
3

Part I - Financial Information
Item 1. Financial Statements

SYNALLOY CORPORATION
Condensed Consolidated Balance Sheets
(in thousands, except par value and share data)
(Unaudited)
 March 31, 2022December 31, 2021
Assets 
Current assets: 
Cash and cash equivalents$1,241 $2,021 
Accounts receivable, net of allowance for credit losses of $456 and $216, respectively
67,819 50,126 
Inventories, net112,114 103,249 
Prepaid expenses and other current assets3,808 3,728 
Assets held for sale797 855 
Total current assets185,779 159,979 
Property, plant and equipment, net42,720 43,720 
Right-of-use assets, operating leases, net30,431 30,811 
Goodwill12,637 12,637 
Intangible assets, net13,661 14,382 
Deferred charges, net278 302 
Other non-current assets, net4,127 4,171 
Total assets$289,633 $266,002 
Liabilities and Shareholders' Equity 
Current liabilities: 
Accounts payable$44,268 $32,318 
Accounts payable - related parties2 2 
Accrued expenses and other current liabilities13,609 12,407 
Current portion of long-term debt2,464 2,464 
Current portion of earn-out liabilities891 1,961 
Current portion of operating lease liabilities1,140 1,104 
Current portion of finance lease liabilities248 233 
Total current liabilities62,622 50,489 
Long-term debt68,610 67,928 
Long-term portion of operating lease liabilities31,748 32,059 
Long-term portion of finance lease liabilities1,362 1,414 
Deferred income taxes2,861 2,433 
Other long-term liabilities76 89 
Total non-current liabilities104,657 103,923 
Commitments and contingencies – See Note 13
Shareholders' equity: 
Common stock, par value $1 per share; authorized 24,000,000 shares; issued 11,085,000 shares
11,085 11,085 
Capital in excess of par value46,028 46,058 
Retained earnings73,340 63,080 
 130,453 120,223 
Less: cost of common stock in treasury - 861,605 and 918,471 shares, respectively
8,099 8,633 
Total shareholders' equity122,354 111,590 
Total liabilities and shareholders' equity$289,633 $266,002 
Note: The condensed consolidated balance sheet at December 31, 2021 has been derived from the audited consolidated financial statements at that date. See accompanying notes to condensed consolidated financial statements.
4

SYNALLOY CORPORATION
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share data)
Three Months Ended March 31,
20222021
Net sales$116,218 $69,778 
Cost of sales93,722 61,043 
Gross profit22,496 8,735 
Selling, general and administrative8,646 6,869 
Acquisition costs and other531  
Proxy contest costs and recoveries (464)
Earn-out adjustments102 225 
Operating income13,217 2,105 
Other expense (income)
Interest expense403 387 
Loss on extinguishment of debt 223 
Change in fair value of interest rate swaps (2)
Other, net(35)162 
Income before income taxes12,849 1,335 
Income tax provision2,589 241 
Net income$10,260 $1,094 
Net income per common share:
Basic$1.00 $0.12 
Diluted$0.99 $0.12 
Weighted average shares outstanding:
Basic10,2099,191
Dilutive effect from stock options and grants11197
Diluted10,3209,288
See accompanying notes to condensed consolidated financial statements.
5

SYNALLOY CORPORATION
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Three Months Ended March 31,
 20222021
Operating activities  
Net income$10,260 $1,094 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation expense2,116 1,817 
Amortization expense721 680 
Amortization of debt issuance costs25 21 
Loss on extinguishment of debt 223 
Deferred income taxes428 (41)
Earn-out adjustments102 225 
Payments on earn-out liabilities in excess of acquisition date fair value(372) 
Provision for losses on accounts receivable240 12 
Provision for losses on inventories496 184 
Loss on disposal of property, plant and equipment(5)28 
Non-cash lease expense107 124 
Change in fair value of interest rate swap (2)
Issuance of treasury stock for director fees254  
Stock-based compensation expense132 187 
Changes in operating assets and liabilities:  
Accounts receivable(17,933)(11,181)
Inventories(9,302)(3,866)
Other assets and liabilities(27)38 
Accounts payable11,950 6,357 
Accrued expenses(959)(569)
Accrued income taxes2,161 3,901 
Net cash provided by (used in) operating activities394 (768)
Investing activities  
Purchases of property, plant and equipment(1,117)(245)
Proceeds from disposal of property, plant and equipment5 18 
Net cash used in investing activities(1,112)(227)
Financing activities  
Borrowings from long-term debt122,068 14,730 
Proceeds from exercise of stock options118  
Payments on long-term debt(121,386)(12,333)
Principal payments on finance lease obligations(62)(10)
Payments on earn-out liabilities(800)(1,029)
Payments for termination of interest rate swap (46)
Payments of deferred financing costs (155)
Net cash (used in) provided by financing activities(62)1,157 
(Decrease) increase in cash and cash equivalents(780)162 
Cash and cash equivalents at beginning of period2,021 236 
Cash and cash equivalents at end of period$1,241 $398 
Supplemental disclosure
Cash paid for:
  Interest$317 $315 
  Income taxes$2 $ 
See accompanying notes to condensed consolidated financial statements.
6

SYNALLOY CORPORATION
Condensed Consolidated Statement of Shareholders' Equity (Unaudited)
(in thousands)

Three Months Ended March 31, 2022
Common StockCapital in Excess of
Par Value
Retained EarningsCost of Common Stock in TreasuryTotal
 Shares Amount
Balance December 31, 202111,085 $11,085 $46,058 $63,080 $(8,633)$111,590 
Net income— — — 10,260 — 10,260 
Issuance of 43,082 shares of common stock from treasury
— — (151)— 405 254 
Exercise of stock options for 13,784 shares, net
— — (11)— 129 118 
Stock-based compensation— — 132 — — 132 
Balance March 31, 202211,085 $11,085 $46,028 $73,340 $(8,099)$122,354 
See accompanying notes to condensed consolidated financial statements.

Three Months Ended March 31, 2021
Common StockCapital in Excess of
Par Value
Retained EarningsCost of Common Stock in TreasuryTotal
 SharesAmount
Balance December 31, 202010,300 $10,300 $37,719 $42,835 $(10,559)$80,295 
Net income— — — 1,094 — 1,094 
Issuance of 25,363 shares of common stock from treasury
— — (238)— 238  
Stock-based compensation— — 187 — — 187 
Balance March 31, 202110,300 $10,300 $37,668 $43,929 $(10,321)$81,576 
See accompanying notes to condensed consolidated financial statements.


7



Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Unless indicated otherwise, the terms "Company," "we," "us," and "our" refer to Synalloy Corporation and its consolidated subsidiaries.

Note 1: Basis of Presentation
Basis of Financial Statement Presentation
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included as required by Regulation S-X, Rule 10-01.

These interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 (the "Annual Report"). The financial results for the interim periods may not be indicative of the financial results for the entire year.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP required management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

COVID-19 Update
The COVID-19 pandemic and related responses by public health and governmental authorities to contain and combat the outbreak and spread have adversely affected many economic sectors, significantly disrupted the global supply chain and fueled producer price and consumer inflation. During the first quarter of 2022, aspects of the Company's business continued to be affected by macroeconomic factors related to the COVID-19 pandemic, specifically with labor shortages at our plants and other areas of our business. We continue to experience demand for our products, however, the full extent of the future impact of the COVID-19 pandemic on the Company's operational and financial performance is currently uncertain and will depend on many factors outside of the Company's control.

Accounting Pronouncements Not Yet Adopted
In March 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-04 "Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting." The ASU, and subsequent clarifications, provide practical expedients for contract modification accounting related to the transition away from the London Interbank Offered Rate (LIBOR) and other interbank offering rates to alternative reference rates. The expedients are applicable to contract modifications made and hedging relationships entered into on or before December 31, 2022. The Company intends to use the expedients where needed for reference rate transition. The Company continues to evaluate this standard update and does not currently expect a material impact to the Company’s financial statements or disclosures.
8

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 2: Acquisitions
Acquisition of DanChem Technologies, Inc.
On October 22, 2021, the Company completed the acquisition of DanChem, a contract manufacturer of chemical products located in Danville, Virginia. The Company accounted for the transaction as a business combination using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) Topic 805 - "Business Combinations." The preliminary purchase price was $34.1 million including $1.5 million in cash obtained through the acquisition. The purchase price was paid in cash and funded through a drawdown of $34.5 million on the Company’s existing revolving credit facility. Amounts outstanding under the revolving line of credit portion of the facility currently bear interest, at the Company's option, at (a) the Base Rate (as defined in the Credit Agreement) plus 0.50%, or (b) LIBOR plus 150%. See Note 8 for more information on the Company's long-term debt.

The table below summarizes the preliminary estimates of fair value of identifiable assets acquired and liabilities assumed in the Acquisition. These preliminary estimates of the fair value are subject to revisions, which may result in an adjustment to the preliminary values presented below.
(in thousands)October 22, 2021
Cash and cash equivalents$1,533 
Accounts receivable, net of allowance for credit losses5,358 
Inventories, net 1,561 
Prepaid expenses and other current assets454 
Property, plant and equipment, net15,697 
Right of use asset, operating leases, net208 
Intangible assets, net5,750 
Total identifiable assets acquired30,561 
Accounts payable1,751 
Accrued expenses and other current liabilities1,622 
Current portion of operating lease liabilities51 
Current portion of finance lease liabilities215 
Deferred income taxes2,542 
Long-term portion of operating lease liabilities157 
Long-term portion of finance lease liabilities1,408 
Total identifiable liabilities assumed7,746 
Net identifiable assets acquired22,815 
Transaction price34,097 
Goodwill$11,282 
The Company is in various phases of valuing the assets and liabilities assumed, including deferred tax balances, and the Company's estimates of these values was still preliminary on March 31, 2022. Therefore, these provisional amounts are subject to change as the Company continues to evaluate information required to complete the valuations throughout the measurement period, which will not exceed one year from the acquisition date.

Goodwill is calculated as the excess of the purchase price over the fair value of the net assets acquired. The recognized goodwill is attributable to operational synergies, assembled workforce and growth opportunities and was allocated to the Company's Specialty Chemicals Segment. Substantially all of the goodwill resulting from this acquisition is not expected to be deductible for tax purposes.

Approximately $0.3 million of one-time, acquisition-related costs, is recognized in acquisition costs and other expenses in the condensed consolidated statement of operations for the three months ended March 31, 2022.

9

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
The Company identified DanChem’s customer relationships, product development know-how, and tradename as finite-lived assets with estimated fair values as of the acquisition date of $5.1 million, $0.5 million, and $0.2 million, respectively. The finite-lived assets are subject to amortization using the straight-line method over 15 years.

Total net sales and operating income for DanChem for the three months ended March 31, 2022 were as follows:
(in thousands)Three Months Ended
March 31, 2022
Net sales$7,474 
Operating income$235 
Note 3: Revenue Recognition
Revenue is generated primarily from contracts to produce, ship and deliver steel and specialty chemical products. The Company’s performance obligations are satisfied and revenue is recognized when control and title of the contract promised goods or services is transferred to our customers for product shipped or services rendered. Revenues are recorded net of any sales incentives and discounts. Sales tax and other taxes we collect with revenue-producing activities are excluded from revenue. Shipping costs charged to customers are treated as fulfillment activities and are recorded in both revenue and cost of sales at the time control is transferred to the customer. Costs related to obtaining sales contracts are incidental and are expensed when incurred. Because customers are invoiced at the time title transfers and the Company’s right to consideration is unconditional at that time, the Company does not maintain contract asset balances. Additionally, the Company does not maintain material contract liability balances, as performance obligations for substantially all contracts are satisfied prior to customer payment for product. The Company offers industry standard payment terms.
The following table presents the Company's revenues, disaggregated by product group. Substantially all of the Company's revenues are derived from contracts with customers where performance obligations are satisfied at a point-in-time.
Three Months Ended March 31,
(in thousands)20222021
Fiberglass and steel liquid storage tanks and separation equipment$114 $141 
Heavy wall seamless carbon steel pipe and tube12,373 7,818 
Stainless steel pipe and tube62,239 39,911 
Galvanized pipe and tube13,771 7,343 
Specialty chemicals27,721 14,565 
Net sales$116,218 $69,778 
Note 4: Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. To measure fair value, we use a three-tier valuation hierarchy based upon observable and non-observable inputs:
Level 1 - Unadjusted quoted prices that are available in active markets for identical assets or liabilities at the measurement date.
Level 2 - Significant other observable inputs available at the measurement date, other than quoted prices included in Level 1, either directly or indirectly, including:
Quoted prices for similar assets or liabilities in active markets;
Quoted prices for identical or similar assets or liabilities in non-active markets;
Inputs other than quoted prices that are observable for the asset or liability; and
Inputs that are derived principally from or corroborated by other observable market data.
Level 3 - Significant unobservable inputs that cannot be corroborated by observable market data and reflect the use of significant management judgment. These values are generally determined using model-based techniques, including option pricing models, discounted cash flow models, probability weighted models, and Monte Carlo simulations.
10

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
The Company's financial instruments include cash and cash equivalents, accounts receivable, accounts payable, earn-out liabilities, a revolving line of credit and long-term debt.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The fair value hierarchy requires the use of observable market data when available. In instances where the inputs used to measure fair value fall into different levels of the fair value hierarchy, the fair value measurement has been determined on the lowest level input that is significant to the fair value measurement in its entirety. Our assessment of the significance of a particular item to the fair value measurement in its entirety requires judgment, including the consideration of inputs specific to the asset or liability.
Level 3: Contingent consideration (earn-out) liabilities
The fair value of contingent consideration ("earn-out") liabilities resulting from the 2018 MUSA-Galvanized acquisition and the 2019 American Stainless acquisition are classified as Level 3. Each quarter-end, the Company re-evaluates its assumptions for all earn-out liabilities and adjusts to reflect the updated fair values. Changes in the estimated fair value of the earn-out liabilities are reflected in operating income in the periods in which they are identified. Changes in the fair value of the earn-out liabilities may materially impact and cause volatility in the Company's operating results. The significant unobservable inputs used in the fair value measurement of the Company's earn-out liabilities are the discount rate, timing of the estimated payouts, and future revenue projections. Significant increases (decreases) in any of those inputs would not have resulted in a material difference in the fair value measurement of the earn-out liabilities for the three months ended March 31, 2022.
The following table presents a summary of changes in fair value of the Company's Level 3 earn-out liabilities measured on a recurring basis for the three months ended March 31, 2022:
(in thousands)MUSA-GalvanizedAmerican StainlessTotal
Balance December 31, 2021$1,106 $855 $1,961 
Earn-out payments during the period
(317)(855)(1,172)
Changes in fair value during the period
102  102 
Balance March 31, 2022$891 $ $891 
For the three months ended March 31, 2022, the Company had no unrealized gains or losses included in other comprehensive income for recurring Level 3 fair value instruments.
Quantitative Information about Significant Unobservable Inputs Used in Level 3 Fair Value Measurements
The following table summarizes the significant unobservable inputs in the fair value measurement of our contingent consideration (earn-out) liabilities as of March 31, 2022:
InstrumentFair Value
March 31, 2022
Principal Valuation TechniqueSignificant Unobservable InputsRangeWeighted
Average
Contingent consideration (earn-out) liabilities$891Probability Weighted Expected ReturnDiscount rate-5%
Timing of estimated payouts2022-
Future revenue projections
$8.9M
$8.9M
The weighted average discount rate was calculated by applying an equal weighting to each contingent consideration's (earn-out liabilities) discount rate. The weighted average future revenue projection was calculated by applying an equal weighting of probabilities to each forecasted scenario within the valuation models to determine the probability weighted sales applicable to the contingent consideration (earn-out liabilities).
Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
During the three months ended March 31, 2022, the Company's only significant measurements of assets or liabilities at fair value on a non-recurring basis subsequent to their initial recognition were certain assets classified as held for sale.

11

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Assets Held for Sale
On February 17, 2021 the Board of Directors authorized the permanent cessation of operations at Palmer and the subleasing of the Palmer facility. As of December 31, 2021 the Company permanently ceased operations at the Palmer facility and determined that the remaining asset group met the criteria to be classified as held for sale, and therefore classified the related assets as held for sale on the consolidated balance sheets. The Company determined that the exit from this business did not represent a strategic shift that had a major effect on its consolidated results of operations, and therefore this business was not classified as discontinued operations. As of March 31, 2022, the remaining Palmer assets continue to be classified as held for sale. The results of operations for this business are included within the Metals Segment for all periods presented in this quarterly report. The Company uses observable inputs, such as prices of comparable assets in active markets to determine the fair value of the remaining assets. The Company classifies these fair value measurements as Level 2.

The assets classified as held for sale are as follows:
(in thousands)March 31, 2022December 31, 2021
Inventory, net$559 $617 
Property, plant and equipment, net238 238 
Assets held for sale$797 $855 
The Company remains obligated under the terms of the leases for the rent and other costs that may be associated with the lease of the facility through 2036. The Company currently has a sublease for a portion of the Palmer facility and is actively pursuing a sublease for the remaining portion of the facility. The Company will continue to dispose of the remaining assets throughout fiscal 2022.
During the three months ended March 31, 2021, the Company had no significant measurements of assets or liabilities at fair value on a non-recurring basis subsequent to their initial recognition.
Fair Value of Financial Instruments
For short-term instruments, other than those required to be reported at fair value on a recurring and non-recurring basis and for which additional disclosures are included above, management concluded the historical carrying value is a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization. Therefore, as of March 31, 2022 and December 31, 2021, the carrying amounts for cash and cash equivalents, accounts receivable, accounts payable, the Company's revolving line of credit and long-term debt, which is based on a variable interest rate, approximate their fair value.
Note 5: Inventories
Inventories are stated at the lower of cost or net realizable value. Cost is determined by either specific identification or weighted average methods. The components of inventories are as follows:
(in thousands)March 31, 2022December 31, 2021
Raw materials$54,654 $48,745 
Work-in-process29,970 25,187 
Finished goods29,280 30,666 
113,904 104,598 
Less: inventory reserves(1,790)(1,349)
Inventories, net$112,114 $103,249 

12

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 6: Property, Plant and Equipment
Property, plant and equipment consist of the following:
(in thousands)March 31, 2022December 31, 2021
Land$723 $723 
Leasehold improvements4,641 4,641 
Buildings53 53 
Machinery, fixtures and equipment110,331 110,127 
Construction-in-progress2,803 1,900 
118,551 117,444 
Less: accumulated depreciation and amortization(75,831)(73,724)
Property, plant and equipment, net$42,720 $43,720 

The following table sets forth depreciation expense related to property, plant and equipment:
Three Months Ended March 31,
(in thousands)20222021
Cost of sales$2,054 $1,734 
Selling, general and administrative62 83 
Total depreciation$2,116 $1,817 

Note 7: Intangible Assets and Deferred Charges
Intangible assets represent the fair value of intellectual, non-physical assets resulting from business acquisitions and are amortized over their estimated useful life using either an accelerated or straight-line method over a period of eight to 15 years.

The balance of intangible assets subject to amortization are as follows:
(in thousands)March 31, 2022December 31, 2021
Intangible assets, gross$28,876 $28,876 
Accumulated amortization of intangible assets(15,215)(14,494)
Intangible assets, net$13,661 $14,382 

Estimated amortization expense related to intangible assets for the next five years are as follows:
(in thousands)
Remainder of 2022$2,163 
20231,433 
20241,336 
20251,238 
20261,141 
20271,044 
Thereafter$5,306 

13

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Deferred Charges
Deferred charges represent debt issuance costs and are amortized over their estimated useful lives using the straight-line method over a period of four years.
The balance of deferred charges subject to amortization are as follows:
(in thousands)March 31, 2022December 31, 2021
Deferred charges, gross$398 $398 
Accumulated amortization of deferred charges(120)(96)
Deferred charges, net$278 $302 

Note 8: Long-term Debt
Long-term debt consists of the following:
(in thousands)March 31, 2022December 31, 2021
Revolving line of credit, due January 15, 2025$66,432 $65,571 
Term loan, due January 15, 20254,642 4,821 
Total long-term debt71,074 70,392 
Less: Current portion of long-term debt(2,464)(2,464)
Long-term debt, less current portion$68,610 $67,928 
The Company and its subsidiaries have a Credit Agreement with BMO Harris Bank, N.A. ("BMO") which provides the Company with a four-year revolving credit facility with up to $150.0 million of borrowing capacity (the "Facility").
The initial borrowing capacity under the Facility totals $110.0 million consisting of a $105.0 million revolving line of credit and a $5.0 million delayed draw term loan. The revolving line of credit includes a $17.5 million machinery and equipment sub-limit which requires quarterly payments of $0.4 million with a balloon payment due upon maturity of the Facility in January 2025. The term loan requires quarterly payments of $0.2 million with a balloon payment due upon maturity of the Facility in January 2025.
We have pledged all of our accounts receivable, inventory, and certain machinery and equipment as collateral for the Credit Agreement. Availability under the Credit Agreement is subject to the amount of eligible collateral as determined by the lenders' borrowing base calculations. Amounts outstanding under the revolving line of credit portion of the Facility currently bear interest, at the Company's option, at (a) the Base Rate (as defined in the Credit Agreement) plus 0.50%, or (b) LIBOR plus 1.50%. Amounts outstanding under the delayed draw term loan portion of the Facility bear interest at LIBOR plus 1.65%. The Facility also provides an unused commitment fee based on the daily used portion of the Facility. The weighted average interest rate per annum was 2.14% as of March 31, 2022.
Pursuant to the Credit Agreement, the Company was required to pledge all of its tangible and intangible properties, including the stock and membership interests of its subsidiaries. The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $7.5 million and (ii) 10% of the revolving credit facility (currently $10.5 million). As of March 31, 2022, the Company was in compliance with all debt covenants.
As of March 31, 2022, the Company had $38.6 million of remaining available capacity under its credit facility.
14

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 9: Leases
Balance Sheet Presentation
Operating and finance lease amounts included in the unaudited condensed consolidated balance sheet are as follows (in thousands):
ClassificationFinancial Statement Line ItemMarch 31, 2022December 31, 2021
AssetsRight-of-use assets, operating leases$30,431 $30,811 
AssetsProperty, plant and equipment1,598 1,640 
Current liabilitiesCurrent portion of lease liabilities, operating leases1,140 1,104 
Current liabilitiesCurrent portion of lease liabilities, finance leases248 233 
Non-current liabilitiesNon-current portion of lease liabilities, operating leases31,748 32,059 
Non-current liabilitiesNon-current portion of lease liabilities, finance leases1,362 1,414 
Total Lease Cost
Individual components of the total lease cost incurred by the Company are as follows:
(in thousands)Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Operating lease cost$1,048 $1,023 
Finance lease cost:
Amortization of right-of-use assets67 9 
Interest on finance lease liabilities9  
Sublease income$(33)$ 
Total lease cost$1,091 $1,032 
Reduction in carrying amounts of right-of-use assets held under finance leases is included in depreciation expense. Minimum rental payments under operating leases are recognized on a straight-line method over the term of the lease including any periods of free rent and are included in selling, general, and administrative expense on the unaudited condensed consolidated statement of operations.
During the fourth quarter of 2021, the Company entered into a sublease agreement with a third party to sublease a portion of the Palmer facility. The sublease agreement continues through the remaining term of the Master Lease Agreement and will expire on September 30, 2036, unless terminated in accordance with the sublease agreement. The sublease provides for an annual base rent of approximately $0.1 million in the first year, which increases on an annual basis by 2.0%. The sublessee is responsible for its pro rata share of certain costs, taxes and operating expenses related to the subleased space. The sublease includes an initial security deposit of $0.1 million.
Future expected cash receipts from the sublease as of March 31, 2022 are as follows:
(in thousands)Sublease Receipts
Remainder of 2022$95 
2023129 
2024132 
2025134 
2026137 
Thereafter1,490 
Total sublease receipts$2,117 
15

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Maturity of Leases
The amounts of undiscounted future minimum lease payments under leases as of March 31, 2022 are as follows:
(in thousands)OperatingFinance
Remainder of 2022$2,548 $211 
20233,818 272 
20243,658 246 
20253,677 233 
20263,683 233 
Thereafter39,866 542 
Total undiscounted minimum future lease payments57,250 1,737 
Imputed interest24,362 127 
Present value of lease liabilities$32,888 $1,610 
Lease Term and Discount Rate
Weighted-average remaining lease termMarch 31, 2022December 31, 2021
Operating leases14.21 years14.43 years
Finance leases6.79 years7.07 years
Weighted-average discount rate
Operating leases8.30 %8.30 %
Finance leases2.29 %2.27 %
During the three months ended March 31, 2022, no right-of-use assets were recognized in exchange for new operating lease liabilities.
Note 10: Shareholders' Equity
Share Repurchase Program
On February 17, 2021, the Board of Directors re-authorized the Company's share repurchase program. The previous share repurchase program had a term of 24 months and terminated on February 21, 2021. The share repurchase program allows for repurchase of up to 790,383 shares of the Company's outstanding common stock over 24 months. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions. Under the program, the purchases will be funded from available working capital, and the repurchased shares will be returned to the status of authorized, but unissued shares of common stock or held in treasury. There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. As of March 31, 2022, the Company has 790,383 shares of its share repurchase authorization remaining.
16

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 11: Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share:
Three Months Ended March 31,
(in thousands, except per share data)20222021
Numerator:  
Net income$10,260 $1,094 
Denominator:  
Denominator for basic earnings per share - weighted average shares
10,209 9,191 
Effect of dilutive securities:  
Employee stock options and stock grants111 97 
Denominator for diluted earnings per share - weighted average shares
10,320 9,288 
Net income per share:
Basic$1.00 $0.12 
Diluted$0.99 $0.12 

The diluted earnings per share calculations exclude the effect of potentially dilutive shares when the inclusion of those shares in the calculation would have an anti-dilutive effect. The Company had an immaterial number of shares of common stock that were anti-dilutive for the three months ended March 31, 2022. The Company had 0.2 million shares of common stock that were anti-dilutive for the three months ended March 31, 2021.
Note 12: Income Taxes
The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax of multiple state jurisdictions. The Company is no longer subject to U.S. federal examinations for years before 2018 or state examinations for years before 2017. During the three months ended March 31, 2022 and 2021, the Company did not identify nor reserve for any unrecognized tax benefits.

Our income tax provision and overall effective tax rates for the periods presented are as follows:
Three Months Ended March 31,
(in thousands)20222021
Income tax provision$2,589 $241 
Effective income tax rate20.2 %18.1 %

The effective tax rate was 20.2% and 18.1% for the three months ended March 31, 2022 and 2021, respectively. The March 31, 2022 effective tax rate was lower than the U.S. statutory rate of 21.0% primarily due to a forecasted reduction in the valuation allowance in the current year. The March 31, 2021 effective tax rate was also lower than the statutory rate of 21.0% primarily due to a reduction in the valuation allowance in the period.
Note 13: Commitments and Contingencies
The Company is from time-to-time subject to various claims, possible legal actions for product liability and other damages, and other matters arising out of the normal conduct of the Company's business.
Management is not currently aware of any asserted or unasserted matters which could have a material effect on the financial condition or results of operations of the Company.
17

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 14: Industry Segments
The Company's business is divided into two reportable operating segments, the Metals Segment and the Specialty Chemicals Segment. The Metals Segment operates as three reporting units that include Bristol Metals, LLC ("BRISMET") and American Stainless Tubing, LLC ("ASTI") (collectively "Welded Pipe & Tube"), Palmer of Texas Tanks, Inc. ("Palmer"), and Specialty Pipe & Tube, Inc. ("Specialty"). As discussed in Note 4, the Company permanently ceased operations at Palmer as of December 31, 2021 and have classified the remaining assets as held for sale. The results of operations for this business are included within the Metals Segment for all periods presented in this quarterly report. The Metals Segment serves markets through pipe and tube and customers in the appliance, architectural, automotive and commercial transportation, brewery, chemical, petrochemical, pulp and paper, mining, power generation (including nuclear), water and waste-water treatment, liquid natural gas ("LNG"), food processing, pharmaceutical, oil and gas and other industries.
The Specialty Chemicals Segment operates as one reporting unit which includes Manufacturers Chemicals, LLC ("MC"), a wholly-owned subsidiary of Manufacturers Soap and Chemical Company ("MS&C"), CRI Tolling, LLC ("CRI") and DanChem Technologies, Inc ("DanChem"). The Specialty Chemicals Segment produces specialty products for the pulp and paper, coatings, adhesives, sealants and elastomers (CASE), textile, automotive, household, industrial and institutional ("HII"), agricultural, water and waste-water treatment, construction, oil and gas and other industries.
The following table summarizes certain information regarding segments of the Company's operations:
Three Months Ended March 31,
(in thousands)20222021
Net sales
Metals Segment$88,497 $55,213 
Specialty Chemicals Segment27,721 14,565 
$116,218 $69,778 
Operating income
Metals Segment$14,492 $2,577 
Specialty Chemicals Segment2,387 1,056 
Unallocated corporate expenses3,029 1,767 
Acquisition costs and other531  
Proxy contest costs and recoveries (464)
Earn-out adjustments
102 225 
Operating income13,217 2,105 
Interest expense403 387 
Loss on extinguishment of debt 223 
Change in fair value of interest rate swap (2)
Other, net(35)162 
Income before income taxes$12,849 $1,335 
As of
(in thousands)March 31, 2022December 31, 2021
Identifiable assets
Metals Segment$177,039 $160,625 
Specialty Chemicals Segment80,342 72,908 
Corporate32,252 32,469 
$289,633 $266,002 
18

Synalloy Corporation
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 15: Subsequent Events
The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the condensed consolidated financial statements.

19


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

This discussion and analysis summarizes the significant factors affecting our consolidated operating results, liquidity, and capital resources during the three months ended March 31, 2022 and 2021, respectively. This discussion and analysis should be read in conjunction with the consolidated financial statements and notes to the consolidated financial statements that are included in our Annual Report on Form 10-K for the year ended December 31, 2021 (the Annual Report), as well as the condensed consolidated financial statements (unaudited) and notes to the condensed consolidated financial statements (unaudited) contained in this report. Unless otherwise specified, all comparisons made are to the corresponding period of 2021. This discussion and analysis is presented in five sections:
Executive Overview
Results of Operations and Non-GAAP Financial Measures
Liquidity and Capital Resources
Material Cash Requirements from Contractual and Other Obligations
Critical Accounting Policies and Estimates
20


Executive Overview
First Quarter 2022 Highlights
Consolidated net sales for the first quarter of 2022 were $116.2 million increasing 66.6%, or $46.4 million, compared to the first quarter of 2021. The increase was primarily driven by increases in average selling price and pounds shipped as well as the Company's acquisition of DanChem in the fourth quarter of 2021, which is discussed in more detail in Note 2 of the notes to the unaudited condensed consolidated financial statements. Excluding the DanChem acquisition, net sales increased 55.8%, or $39.0 million, over the first quarter of 2021.
Consolidated net income increased to $10.3 million, or $0.99 diluted earnings per share, in the first quarter of 2022, compared to net income of $1.1 million, or $0.12 diluted earnings per share, in the first quarter of 2021. Excluding the DanChem acquisition, consolidated net income increased to $10.0 million and earnings per share increased to $0.97 diluted earnings per share.
During the first quarter of 2022, the Company generated cash flows from operating activities of $0.4 million driven by increased profitability, partially offset by working capital use due to the rise in raw material costs. During the quarter, the Company also used $1.1 million for capital expenditures focusing on growth and maintenance projects to continue to improve operational efficiencies.

In the first quarter of 2022, we experienced another period of profitable growth continuing the sustained levels of high performance from 2021 across both business segments. In our Metals Segment, strong growth in the quarter was driven by the pass through of rising input and other raw material costs. In our Specialty Chemicals Segment, competitive price adjustments as well as the acquisition of DanChem helped to offset continued labor and raw material constraints to drive earnings growth. The first quarter of 2022 includes $7.5 million in net sales and $0.2 million in operating income attributable to the DanChem operations acquired in the fourth quarter of 2021.

Impacts of COVID-19
We continue to monitor the impact of COVID-19 on all aspects of our business. We are a company operating in a critical infrastructure industry, as defined by the U.S. Department of Homeland Security. Consistent with federal guidelines and with state and local orders to date, we have continued to operate across our footprint throughout the COVID-19 pandemic. Ensuring the health and safety of our employees, and all who visit our sites, is our top priority, and we are following all U.S. Centers for Disease Control and Prevention and state and local health department guidelines. Following the onset of COVID-19 and its negative effects on our business, most prominently reflected in our fiscal 2020 results, global economic conditions improved during fiscal 2021, resulting in increased demand for our products. Beginning in fiscal 2021 and continuing through the first quarter of fiscal 2022, there has been a trend in many parts of the world of increasing availability and administration of vaccines against COVID-19, as well as an easing of restrictions on individual, business, and government activities. The existence of new or enduring variant strains of COVID-19 may lead to a rise in infections, which could cause delays in the easing of restrictions previously in place and the implementation of new restrictions and mandates, and there are ongoing global impacts resulting directly or indirectly from the pandemic including labor shortages, logistical challenges such as increased port congestion, and increases in costs for certain goods and services. While the ongoing effects of the COVID-19 pandemic could negatively impact our results of operations, cash flows, and financial position, the current level of uncertainty over the economic and operational impacts of COVID-19 means the related financial impact cannot be reasonably estimated at this time. See Part I - Item 1A, "Risk Factors," included in our Annual Report on Form 10-K for our risk factors regarding risks associated with the COVID-19 pandemic.
21


Results of Operations
Consolidated Performance Summary
Consolidated net sales for the first quarter of 2022 were $116.2 million, an increase of $46.4 million, or 66.6%, compared to net sales for the first quarter of 2021. The increase in net sales was primarily driven by a 62.7% increase in average selling price and a 2.3% increase in pounds shipped. Excluding DanChem, net sales increased $39.0 million, or 55.8%, to $108.7 million primarily driven by a 60.9% increase in average selling price partially offset by a 3.3% decrease in pounds shipped.
For the first quarter of 2022, consolidated gross profit increased 157.5% to $22.5 million, or 19.4% of sales, compared to $8.7 million, or 12.5% of sales in the first quarter of 2021. The increase in dollars and percentage of sales were attributable to increased selling prices partially offset by increasing raw material and freight costs.
Consolidated selling, general, and administrative expense (SG&A) for the first quarter of 2022 increased $1.8 million to $8.6 million, or 7.4% of sales, compared to $6.9 million, or 9.8% of sales in the first quarter of 2021. The changes in SG&A were primarily driven by:
Increases in salaries, wages and benefits of $1.1 million primarily driven by increased personnel costs;
Increases in bad debt expense of $0.2 million primarily driven by the increase in accounts receivable;
Increases in travel expense of $0.2 million primarily driven by continued easing of COVID-19 restrictions; and,
Increases in other expenses of $0.3 million primarily driven by increases in utilities, taxes, licenses and insurance.
Consolidated operating income in the first quarter of 2022 totaled $13.2 million compared to operating income of $2.1 million in the first quarter of 2021. The operating increase in the first quarter of 2022 was primarily driven by increases in average selling price and increased demand driven sales.
Metals Segment
Net sales for the Metals Segment in the first quarter of 2022 totaled $88.5 million, an increase of $33.3 million, or 60.3%, from the first quarter of 2021. The increase was primarily driven by a 64.5% increase in average selling price partially offset by 2.6% decrease in pounds shipped.
The net sales increase for the first quarter of 2022 compared to the first quarter of 2021 is summarized as follows:
($ in thousands)$%Average selling priceUnits
shipped
Fiberglass and steel liquid storage tanks and separation equipment$(27)(19.1)%457.2%(85.4)%
Heavy wall seamless carbon steel pipe and tube4,555 58.3%41.4%11.9%
Stainless steel pipe and tube22,252 55.7%61.6%(3.8)%
Galvanized pipe and tube6,504 88.9%104.0%(7.4)%
   Total increase$33,284 
SG&A expense for the first quarter of 2022 decreased $0.1 million to $4.1 million, or 4.7% of sales, compared to $4.2 million, or 7.6% of sales in the first quarter of 2021. The changes in SG&A were primarily driven by a decrease in professional fees of $0.1 million.
Operating income increased $12.2 million, or 571.8%, to $14.3 million for the first quarter of 2022 compared to $2.1 million for the first quarter of 2021. The current quarter increase in operating income was primarily driven by average selling price increases due to pass through of raw material cost fluctuations.
Specialty Chemicals Segment
Net sales for the Specialty Chemicals Segment in the first quarter of 2022 totaled $27.7 million, representing a $13.2 million, or 90.3%, increase from the first quarter of 2021. The increase was driven by a 60.8% increase in average selling price and a 10.7% increase in pounds shipped, excluding trial and dedicated facility revenue. Excluding DanChem, net sales totaled $20.2 million, representing a $5.7 million, or 39.0%, increase primarily driven by a 45.2% increase in average selling price partially offset by a 4.3% decrease in pounds shipped.
22


SG&A expense for the first quarter of 2022 increased $0.6 million to $1.6 million, or 5.7% of sales, compared to $1.0 million, or 7.0% of sales in the first quarter of 2021. The increase in SG&A expense was driven by the acquisition of DanChem in the fourth quarter of 2021.
Operating income increased $1.3 million, or 126.1%, to $2.4 million for the first quarter of 2022 compared to $1.1 million for the first quarter of 2021. The increase in operating income is primarily driven by increases in average selling price, favorable operational efficiencies and the acquisition of DanChem in fourth quarter of 2021.
Other Items
Unallocated corporate expenses for the first quarter of 2022 increased $1.3 million, or 71.5%, to $3.0 million, or 2.6% of sales, compared to $1.8 million, or 2.5% of sales, in the prior year comparative period. The first quarter 2022 increases resulted primarily from decreases in allocated costs of $1.0 million and increases in taxes, licenses and insurance of $0.3 million.
Interest expense was $0.4 million for both the first quarter of 2022 and the first quarter of 2021.
The effective tax rate was 20.2% and 18.1% for the three months ended March 31, 2022 and 2021, respectively. The March 31, 2022 effective tax rate was lower than the U.S. statutory rate of 21.0% primarily due to a forecasted reduction in the valuation allowance in the current year. The March 31, 2021 effective tax rate was lower than the statutory rate of 21.0% primarily due to a reduction in the valuation allowance in the period.
Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States ("GAAP"), we use the following non-GAAP financial measures: EBITDA and Adjusted EBITDA. Management believes that these non-GAAP measures provide additional useful information to allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
EBITDA and Adjusted EBITDA
We define "EBITDA" as earnings before interest (including change in fair value of interest rate swap), income taxes, depreciation and amortization. We define "Adjusted EBITDA" as EBITDA further adjusted for the impact of non-cash and other items we do not consider in our evaluation of ongoing performance. These items include: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, shelf registration costs, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring and severance costs from net income. We caution investors that amounts presented in accordance with our definitions of EBITDA and Adjusted EBITDA may not be comparable to similar measures disclosed by other companies because not all companies calculate EBITDA and Adjusted EBITDA in the same manner. We present EBITDA and Adjusted EBITDA because we consider them to be important supplemental measures of our performance and investors' understanding of our performance is enhanced by including these non-GAAP financial measures as a reasonable basis for comparing our ongoing results of operations.










23


Consolidated EBITDA and Adjusted EBITDA are as follows:
Three Months Ended March 31,
($ in thousands)20222021
Consolidated
Net income$10,260 $1,094 
Adjustments:
Interest expense403 387 
Change in fair value of interest rate swap— (2)
Income taxes2,589 241 
Depreciation2,116 1,817 
Amortization721 680 
EBITDA16,089 4,217 
Acquisition costs and other531 — 
Proxy contest costs and recoveries— (464)
Loss on extinguishment of debt— 223 
Earn-out adjustments102 225 
Loss on investments in equity securities and other investments— 363 
Stock-based compensation132 187 
Non-cash lease expense107 124 
Adjusted EBITDA$16,961 $4,875 
% of sales14.6 %7.0 %

Metals Segment EBITDA and Adjusted EBITDA are as follows:
Three Months Ended March 31,
($ in thousands)20222021
Metals Segment
Net income$14,424 $2,538 
Adjustments:
Depreciation1,213 1,393 
Amortization625 680 
EBITDA16,262 4,611 
Earn-out adjustments102 225 
Stock-based compensation35 38 
Metals Segment Adjusted EBITDA$16,399 $4,874 
% of segment sales18.5 %8.8 %






24


Specialty Chemicals Segment EBITDA and Adjusted EBITDA are as follows:
Three Months Ended March 31,
($ in thousands)20222021
Specialty Chemicals Segment
Net income$2,378 $1,055 
Adjustments:
Interest expense— 
Depreciation886 386 
Amortization96 — 
EBITDA3,369 1,441 
Stock-based compensation31 
Specialty Chemicals Segment Adjusted EBITDA$3,375 $1,472 
% of segment sales12.2 %10.1 %

Liquidity and Capital Resources
We closely manage our liquidity and capital resources. Our liquidity requirements depend on key variables, including level of investment required to support our business strategies, the performance of our business, capital expenditures, credit facilities and working capital management. Capital expenditures and share repurchases are a component of our cash flow and capital management strategy which we can adjust in response to economic and other changes in our business environment. We have a disciplined approach to capital allocation focusing on priorities that support our business and growth.
Sources of Liquidity
Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of March 31, 2022, we held $1.2 million of cash and cash equivalents, as well as $38.6 million of remaining available capacity on our revolving line of credit. We believe our sources of liquidity will be sufficient to fund operations and anticipated capital expenditures as well as repay our debt obligations as they become due over the next 12 months.
Cash Flows

Cash flows from total operations were as follows:
Three Months Ended March 31,
(in thousands)20222020
Total cash (used in) provided by:
Operating activities$394 $(768)
Investing activities(1,112)(227)
Financing activities(62)1,157 
Net (decrease) increase in cash and cash equivalents$(780)$162 

Operating Activities
The increase in cash provided by operating activities for the three months ended March 31, 2022 compared to cash used in operating activities in the three months ended March 31, 2021 was primarily driven by increased net income in the first quarter of 2022 compared to the first quarter of 2021 and changes in working capital. Accounts receivable increased for the first three months of 2022 by $17.9 million, compared to an increase of $11.2 million for the first three months of 2021, driving a reduction of $6.7 million in operating cash flows for the first quarter of 2022. Inventories increased $9.3 million in the first three months of 2022 compared to an increase of $3.9 million in the first three months of 2021, driving a reduction of $5.4 million in operating cash flow for the first quarter of 2022. The increase in accounts receivable and inventory was due to a larger increase in sales volume over prior quarter in the first three months of 2022 than the increase experienced in the first three months of 2021, increases in DSO from 44 days during the first three months of 2021 to 46 days in the first three months
25


of 2022 and higher inventory purchases to meet customer demand in the first three months of 2022. The increases in cash used from accounts receivable and inventory were partially offset by increases in accounts payable due to higher inventory purchases to meet customer demand and an increase in days payables outstanding from 32 days in the first three months of 2021 to 37 days in the first three months of 2021.
Investing Activities
Net cash used in investing activities primarily consists of transactions related to capital expenditures. The increase in cash used in investing activities for the three months ended March 31, 2022 compared to the three months ended March 31, 2021 was primarily due to a increases in capital expenditures in the current year compared to the prior year.
Financing Activities
Net cash used in financing activities primarily consists of transactions related to our long-term debt. The increase in cash used in financing activities for the three months ended March 31, 2022 compared to cash provided by financing activities for the three months ended March 31, 2021 was primarily due to payments towards the Company's revolving line of credit and payments for the Company's earnout liabilities partially offset by borrowings from the Company's revolving line of credit and proceeds received from the exercise of stock options in the current year.
Long-term Debt
The Company and its subsidiaries have a Credit Agreement with BMO providing the Company with a four-year revolving credit facility, maturing on January 15, 2025, and providing the Company with up to $150.0 million of borrowing capacity. As of March 31, 2022, the Company had $71.1 million of total borrowings outstanding with its lender, an increase of $0.7 million from the balance at December 31, 2021. The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $7.5 million and (ii) 10% of the revolving credit facility (currently $10.5 million). As of March 31, 2022, the Company was in compliance with all debt covenants. See Note 8 in the notes to the unaudited condensed consolidated financial statements for additional information on the Company's line of credit.
Share Repurchases and Dividends
We have a share repurchase program, authorized by the Company's Board of Directors, that is executed through purchases made from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions. Shares repurchased are returned to status of authorized, but unissued shares of common stock or held in treasury. The Company repurchased no shares during the three months ended March 31, 2022 and 2021. As of March 31, 2022, the Company has 790,383 shares of its share repurchase authorization remaining.
At the end of each fiscal year the Board of Directors reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate. In 2021, no dividends were declared or paid by the Company.

Other Financial Measures
Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as:

Liquidity Measure:
Current ratio = current assets divided by current liabilities. The current ratio will be determined by the Company using generally accepted accounting principles, consistently applied.
Leverage Measure:
Debt to capital = total debt divided by total capital. The debt to capital ratio will be determined by the Company using generally accepted accounting principles, consistently applied.
Profitability Ratio:
Return on average equity ("ROAE") = net income divided by the trailing 12-month average of equity. The ROAE will be determined by the Company using generally accepted accounting principles, consistently applied.

26


Results of these additional measures are as follows:
March 31, 2022December 31, 2021
Current ratio3.03.3
Debt to capital37%39%
Return on average equity28.8%21.1%
Material Cash Requirements from Contractual and Other Obligations
As of March 31, 2022, our material cash requirements for our known contractual and other obligations were as follows:
Debt Obligations and Interest Payments - Outstanding obligations on our revolving credit facility and term loan were $66.4 million and $4.6 million, respectively, with $2.5 million payable within 12 months. The interest payments on our remaining borrowings will be determined based upon the average outstanding balance of our borrowings and the prevailing interest rate during that time. See Note 8 for further detail of our debt and the timing of expected future payments.
Operating and Finance Leases - The Company enters into various lease agreements for the real estate and manufacturing equipment used in the normal course of business. Operating and finance lease obligations were $34.5 million, with $1.4 million payable within 12 months. See Note 9 for further detail of our lease obligations and the timing of expected future payments.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures. We expect capital spending to be as much as $8.1 million for the remainder of fiscal 2022.
Critical Accounting Policies and Estimates
We describe our significant accounting policies in Note 1, Summary of Significant Accounting Policies, in the notes to the consolidated financial statements presented in the Annual Report on Form 10-K for the year ended December 31, 2021. We discuss our critical accounting estimates in Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, in the Annual Report on Form 10-K for the year ended December 31, 2021. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of 2021.
Item 3. Quantitative and Qualitative Disclosures about Market Risks
We are a smaller reporting company as defined in Rule 12b-2 of the Exchange Act; therefore, we are not required to provide the information required by this Item.
27


Item 4. Controls and Procedures
Changes in Internal Control over Financial Reporting
Other than the actions taken as described below under “Remediation Efforts to Address Material Weaknesses”, there were no changes in the Company's internal control over financial reporting during the first quarter of 2022, which were identified in connection with management's evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.
Remediation Efforts to Address Material Weaknesses
In response to the material weaknesses identified in Management’s Report on Internal Control Over Financial Reporting as set forth in Item 9A “Controls and Procedures” in the 2021 Form 10-K, the Company, with oversight from the Audit Committee of the Board of Directors, developed a plan to remediate the material weaknesses at Synalloy. The remediation actions include the following:
Providing relevant training on internal controls over financial reporting to control owners and control preparers;
Hiring accounting and finance resources with relevant public company experience and evaluating and realigning roles and responsibilities of management;
Enhancing/designing/implementing controls over physical inventory counts and inventory valuation;
Enhancing/designing/implementing controls over revenue recognition and accounts receivable; and,
Enhancing/designing/implementing controls over period-end financial reporting, account reconciliation and account analyses processes.
As the Company continues to evaluate the control deficiencies that gave rise to the material weaknesses, the Company may determine additional remediation measures are necessary.
PART II
Item 1. Legal Proceedings
It is not unusual for us and our subsidiaries to be involved in various unresolved legal actions, administrative proceedings and claims in the ordinary course of business involving, among other things, product liability, commercial, employment, workers' compensation, and environmental matters. We establish reserves in a manner that is consistent with accounting principles generally accepted in the U.S. for costs associated with such matters when a liability is probable and those costs are capable of being reasonably estimated. We cannot predict with any certainty the outcome of these unresolved legal actions or the range of possible loss or recovery. Based on current information, however, we believe that the eventual outcome of these unresolved legal actions, either individually or in the aggregate, will not have a material adverse effect on our financial position, results of operations or cash flows. There were no material changes in our Legal Proceedings, as discussed in Part I, Item 3 in the Company's Annual Report on Form 10-K for the period ending December 31, 2021.
Item 1A. Risk Factors
There were no material changes in our assessment of risk factors as discussed in Part I, Item 1A in the Company's Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
28



Item 6. Exhibits
Exhibit No.